Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Share News (BOY)

Share Price Information for Bodycote (BOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 682.00
Bid: 676.00
Ask: 678.00
Change: 3.00 (0.44%)
Spread: 2.00 (0.296%)
Open: 681.00
High: 682.00
Low: 674.00
Prev. Close: 679.00
BOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Ted Baker Rises On "Resilient" Performance

Thu, 06th Dec 2018 10:48

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - LOSERS----------Just Eat, down 6.0%. Shares in the online takeaway platform were lower following its demotion from the FTSE 100 index after the market close on Wednesday.----------FTSE 250 - WINNERS----------Genus, up 10%. The animal genetics company was upgraded to Buy from Hold by Keppler Cheuvreux. ----------Ted Baker, up 3.2%. The fashion retailer reported a "resilient" performance amid challenging trading conditions, as it responded to allegations of harassment against its founder and chief executive. For the 16 weeks to December 1, the company said group revenue decreased by 0.2% on the prior year, due to an anticipated decline in wholesale sales, which fell 6.5%. However, a good retail sales performance, up 2.3% including e-commerce, "largely offset" the overall decline. E-commerce, on a standalone basis, saw sales up 18%, representing now 30% of the retailer's total sales. Ted Baker has in the past week being rocked by a harassment scandal, after a Sky News report on Sunday revealed the company's staff had launched a online petition to put an end to forced "hugging" and inappropriate touching and comments by Founder & Chief Executive Ray Kelvin. On Thursday, Ted Baker confirmed the appointment of Herbert Smith Freehills to conduct an independent external investigation into the allegations.----------Ferrexpo, up 0.9%. The iron pellet producer said it will return USD40 million to shareholders via a special dividend payment due to strong cash generation. The company declared a special interim dividend of 6.6 cents per share for 2018, versus 3.3 cents declared in 2017. The special payout will be paid on January 14 to shareholders on the register at the close of business on Friday next week. The company said it has continued to trade as expected in the second half of 2018, with iron pellet premiums remaining at the high levels seen in the first half and strong cash generation enabling debt reduction and capital expenditure. Ferrexpo continues to believe seaborne pellet demand to be strong in 2019 on the back of constrained supply. ----------FTSE 250 - LOSERS----------Thomas Cook, down 9.0%. The troubled travel agent was giving back gains from after closing 47% higher on Wednesday. Last week, Thomas Cook warned on profit, cautioned on its outlook and suspended its final dividend. The company was demoted from the FTSE 250 as part of the FTSE index review changes. ----------Bodycote, 7.5%. UBS downgraded the heat treatment and coating services firm to Neutral from Buy. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Trakm8 Holdings, up 15% at 20.7 pence. The telematics and data supply firm said it plans to raise GBP3.0 million to fund working capital requirements via a subscription of shares. The company plans to issue 13.9 million shares at 22.00 pence each, a 22% premium to its closing price on Wednesday. Trakm8 said some of its directors have decided to subscribe for GBP700,000 worth of shares. ----------OTHER MAIN MARKET AND AIM - LOSERS----------Gresham Technologies, down 38%. The real-time transaction and enterprise data software company said it expects its adjusted earnings for 2018 to be "materially" below current market expectations due to contract delays. Gresham warned that due to some significant high-margin software licence deals being delayed into 2019, and the company's "ongoing" investments in product innovation and business development, its adjusted earnings before interest, taxation, depreciation and amortisation for 2018 will fall below expectations. Gresham said it expects revenue for the year to be "broadly" in-line with expectations, due to continued strong growth for its flagship Clareti Transaction Control system, if its planned software deals are contracted and recognised as revenue in 2018. Gresham said 80% of its planned revenue for the year has been contracted due to the "strong demand" for its Clareti Transaction Control. ----------eve Sleep, down 16% at 11.90p. The online mattress retailer said it has secured subscribers for GBP9.9 million worth of new shares, significantly lower than the previously announced GBP15 million equity issue plan. The company said that funds managed by Woodford Investment Management have indicated that they intend to subscribe for up to GBP8.0 million worth of shares at 10.00p per share. Channel 4, an investor of the company which also provides advertising services to eve Sleep, intends to subscribe for GBP900,000. In November, eve Sleep had said it was to raise around GBP15 million of new equity to double its product range and invest in marketing activities. The company added that trading has continued to be strong which will boost annual revenue.----------

More News
2 Jun 2020 09:39

UK BROKER RATINGS SUMMARY: Berenberg Downgrades TUI To Sell From Hold

UK BROKER RATINGS SUMMARY: Berenberg Downgrades TUI To Sell From Hold

Read more
28 May 2020 09:38

TOP NEWS: Bodycote To Cut 700 Staff, Shutter Plants As Revenue Falls

TOP NEWS: Bodycote To Cut 700 Staff, Shutter Plants As Revenue Falls

Read more
28 May 2020 07:39

Bodycote cuts more than 700 jobs after revenue slumps

(Sharecast News) - Bodycote is cutting more than 700 jobs and closing factories after underlying revenue fell by more than a third in April because of the Covid-19 shutdown.

Read more
11 May 2020 09:33

UK BROKER RATINGS SUMMARY: Goldman Sachs Cuts Next To Neutral From Buy

UK BROKER RATINGS SUMMARY: Goldman Sachs Cuts Next To Neutral From Buy

Read more
24 Apr 2020 09:38

UK BROKER RATINGS SUMMARY: Jefferies Cuts Diageo, Goldman Cuts Hikma

UK BROKER RATINGS SUMMARY: Jefferies Cuts Diageo, Goldman Cuts Hikma

Read more
23 Apr 2020 10:59

Bodycote Pulls 14.0 Pence Final Payout Amid Covid-19 Uncertainty

Bodycote Pulls 14.0 Pence Final Payout Amid Covid-19 Uncertainty

Read more
23 Apr 2020 08:02

Bodycote defers dividend decision due to Covid-19

(Sharecast News) - Bodycote said on Thursday that it will defer a decision on its 2019 dividend until there is more clarity on the impact of the coronavirus pandemic.

Read more
16 Apr 2020 18:00

Henderson High Outperforms Benchmark In 2019, Increases Dividend

Henderson High Outperforms Benchmark In 2019, Increases Dividend

Read more
16 Apr 2020 15:59

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
14 Apr 2020 09:50

UK BROKER RATINGS SUMMARY: Barclays Raises Centrica And Cuts SSE

UK BROKER RATINGS SUMMARY: Barclays Raises Centrica And Cuts SSE

Read more
6 Apr 2020 10:57

UK WINNERS & LOSERS SUMMARY: Rolls-Royce Up As Bad News Is No Surprise

UK WINNERS & LOSERS SUMMARY: Rolls-Royce Up As Bad News Is No Surprise

Read more
6 Apr 2020 10:40

Bodycote Completes Ellison Buy, Reviewing Final Dividend Proposal

Bodycote Completes Ellison Buy, Reviewing Final Dividend Proposal

Read more
6 Apr 2020 07:44

Bodycote Q1 not 'significantly' impacted by Covid-19; final divi under review

(Sharecast News) - Bodycote said on Monday that first-quarter trading has not been "significantly" impacted by the Covid-19 pandemic but that its proposed final dividend is under review given current uncertainty.

Read more
30 Mar 2020 09:48

UK BROKER RATINGS SUMMARY: RBC Raises Rentokil But Cuts AB Foods

UK BROKER RATINGS SUMMARY: RBC Raises Rentokil But Cuts AB Foods

Read more
26 Mar 2020 09:30

UK BROKER RATINGS SUMMARY: JPMorgan And Goldman Differ Over Rentokil

UK BROKER RATINGS SUMMARY: JPMorgan And Goldman Differ Over Rentokil

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.